Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs7606767 | chr2:3483808 | G/A | 1.99E-5 | 133 | 40.57 | 66.17 | 25.32 | KM Plot |
| TGCT | rs76204283 | chr17:42111092 | A/G | 0 | 128 | 45.1 | 33.53 | 0.57 | KM Plot |
| TGCT | rs76217707 | chr10:85704243 | G/A | 4.34E-5 | 128 | 50.97 | 24.25 | 18.07 | KM Plot |
| TGCT | rs7629698 | chr3:172428508 | C/T | 1.49E-5 | 134 | 24.15 | 37.3 | 45.1 | KM Plot |
| TGCT | rs76345698 | chr16:30946165 | G/A | 1.72E-13 | 132 | 39.38 | 81.3 | 17.1 | KM Plot |
| TGCT | rs76358186 | chr6:15241548 | T/C | 6.08E-5 | 133 | 37.95 | 45.1 | NA | KM Plot |
| TGCT | rs7652606 | chr3:108160339 | A/G | 1.14E-5 | 134 | 46.3 | 26.4 | 4.78 | KM Plot |
| TGCT | rs76533309 | chr2:29495816 | T/C | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs76537144 | chr6:15251456 | T/C | 3.36E-5 | 133 | 37.7 | 45.93 | NA | KM Plot |
| TGCT | rs7658340 | chr4:57304583 | G/T | 0.00016 | 129 | 39.38 | 55.48 | 68.97 | KM Plot |
| TGCT | rs76773322 | chr6:28345212 | G/C | 0 | 133 | 46.07 | 29.65 | 0.57 | KM Plot |
| TGCT | rs768616 | chr6:157001201 | A/G | 0.000115 | 133 | 41.27 | 60.63 | 59.27 | KM Plot |
| TGCT | rs76897964 | chr2:29493543 | A/G | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs76909681 | chr5:74577228 | G/A | 2.0E-5 | 127 | 45.1 | 28.8 | 9.27 | KM Plot |
| TGCT | rs7703762 | chr5:1797548 | C/T | 4.04E-7 | 133 | 42.27 | 45.83 | 20.6 | KM Plot |